Specialty Pharmacy, Infusion

& Pharma Services

Available for acquisition is a specialty pharmacy headquartered in South Central region and holding multi-State licenses. The company is accredited by multiple accreditation agencies in order to showcase their focus on training and compliance. They cover a multitude of specialty pharmacy products in the following sectors: RA/GI/Dermatology, Inflammation/Pain, Allergy, Migraine – Oral/Biological, Urology, Hepatitis-C, HIV and Psychiatric products.  In the trailing twelve month period ending March 2023, the business generated revenues exceeding $118.8MM with EBITDA exceeding $4.42MM for the period.

Territory Expansion: The company has pending licenses in contiguous states in which manufacturers have identified a need for a specialty pharmacy company. This will provide organic growth into those additional states.

Specialty Retail Pharmacy – Multiple Locations

Company Highlights

• Revenue $ 43MM
• Adjusted EBITDA: $ 2M
• 3 pharmacy locations
• Established Business with Strong Reputation
• Growing & Profitable
• Expansion Opportunities

ESTABLISHED PHARMACY: The Company is an established pharmacy that brings trust and dependability to the community it serves. An experienced and skilled team of professionals provide exceptional customer service and products to the clients they serve.

PRODUCT/PAYOR MIX: The Company as a product mix of 80% Specialty Pharmacy and 20% Retail pharmacy. Of the Specialty Pharmacy, the mix is dermatology 70%, HIV 5%, pain management 15% and wound care 10%. The Company largely deals with commercial payors as well as some Medicare and Medicaid.

GROWTH OPPORTUNITY: The Company has identified additional markets contiguous to its current locations that have referrals sources ready to partner with them. Additionally, opportunity to diversity product lines and expand pharmacy offerings.

FINANCIAL PERFORMANCE: In FY year ending 2018, the Company generated revenue of $62.6M with an adjusted EBITDA of $2.1M.

Specialty Pharmacy - Dermatology (NE)

Available for acquisition is a Northeast US specialty pharmacy provider with strong contract and referral relationships. The Company provides specialty pharmacy medications to patients and is licensed in multiple states.

The staff at the company includes highly trained and experienced healthcare professionals including licensed pharmacists, pharmacy technicians and administrative personnel that serve the Company’s growing patient population.

The Company’s reputation for servicing specialty pharmacy patients provides strong margins and a sustainable EBITDA. Over the trailing twelve months ended December 2022, the business generated gross revenues of $43 MM with an adjusted EBITDA exceeding $ 2.0 MM. The Company continues to grow with solid business and referral relationships and is well positioned for continued growth.

Specialty Pharmacy - Dermatology (WE)

[NOT CURRENTLY AVAILABLE]

Available for acquisition is a southwestern US based specialty pharmacy provider with strong contract and referral relationships in the home health care industry. The Company provides specialty pharmacy medications to patients on a private pay basis. The company is licensed in 48 states.

The staff at the company includes highly trained and experienced healthcare professionals including licensed pharmacists, pharmacy technicians and administrative personnel that serve the Company’s growing patient population.

The Company’s reputation servicing specialty pharmacy patients provides strong margins and a sustainable EBITDA. Over the trailing twelve months ended June 2022, the business generated gross revenues of $22.919 MM with an adjusted EBITDA exceeding $ 3.827 MM. The Company continues to grow with solid business and referral relationships and is well positioned for continued growth.

Specialty & Long Term Care Pharmacy

[UNDER LOI]

Available for acquisition is a southeastern US based specialty retail and LTC pharmacy provider with strong contract and payor relationships. The Company provides specialty pharmacy medications to patients in their home care and LTC settings. The dedicated staff includes highly trained and experienced healthcare professionals including licensed pharmacists, pharmacy technicians and administrative personnel that serve the Company’s growing patient population.

The Company’s reputation servicing specialty pharmacy patients provides strong margins and a sustainable EBITDA. Over the trailing twelve months ended June 2022, the business generated gross revenues of $40.41 MM with an adjusted EBITDA exceeding $ 3.52 MM. The Company continues to grow with solid business and referral relationships and is well positioned for continued growth.

Mobility, Durable Medical Equipment & Supply Provider

Available for acquisition is this community-based provider of Mobility and Durable Medical Equipment & Supplies provider. The Company enjoys a strong reputation in the marketplace based on the integrity of their staff, individualized customer service and many years of experience and knowledge.

The company has carved out niche sourcing and providing the most basic items needed as well as specialty items; both in the rehab and clinical sector. The company’s longevity in the industry has positioned them as one of the top companies in the state for case managers, physicians, and payor sources.

With strong payor contracts and referral relationships in the New England area, this company would be an excellent opportunity. This well-established company would be an excellent addition to a strategic buyer looking to expand into this geographic area or add on to their existing business.

Aesthetic Device & Technology Manufacturer

Available for acquisition is this leader in micro needling manufacturing and distributor of premier skincare products and medical aesthetic device technologies. This established company has been in business for over 16 years. The company focuses on designing and developing products that enhance the patient experience and optimize treatment results. In April of 2020, the company achieved FDA clearance for one of its major aesthetic devices – as well as a patent in 2021.

The company provides its customers with the most comprehensive product knowledge, elite device training, and advanced treatment techniques for procedures such as Micro needling and PRP Therapy. In addition to its growing business based in the United States, the company also has distribution in the UK, Ireland & South Africa. The TTM Revenue through 2023 is $11.3M, with adjusted EBITDA of $2.6MM. Financials are on a cash basis.

The company has invested in its infrastructure for sales growth & expansion in FY 2023.

Summary of Key Facts:

• Positive Cash Flow with existing customers, recurring revenues
• Established and expanding market presence both domestically and internationally.
• New products launched in 2022 and investment in sales infrastructure for continued growth.

Urgent Care Centers (UNDER LOI)

Available for acquisition is a Mid-Atlantic US based urgent care center provider with strong contract and payor relationships in the urgent care sector. The Company provides urgent care services to patients at the Company’s multiple locations.

The staff at the company includes highly trained and experienced healthcare professionals including physicians, physical therapists, medical assistants, and administrative personnel that serve the Company’s growing patient population. Additional locations have been added during the past 12 months which offer continued growth opportunities.

The Company’s reputation servicing urgent care patients provides strong margins and a sustainable EBITDA. Over the trailing twelve months ended June 2022, the business generated gross revenues of $6.81 MM with an adjusted EBITDA exceeding $ 2.01 MM. The Company continues to grow with solid business and referral relationships and is well positioned for continued growth.

Multi-State Behavioral Health Residential Addiction Treatment

This established and growing behavioral health platform is a licensed and JCAHO accredited residential detox and addiction treatment provider currently operating three locations in three states totaling 90 beds, with expansion underway to add two additional locations in late 2023 and mid-2024. When complete, the Company will operate approximately 157 beds in 5 locations, all but with owned real estate in all but one location. 

The Company is known for its customized approach to treatment, leveraging multiple modalities, including dialectical behavior therapy, cognitive behavioral therapy, trauma informed, and family therapy. The continuum of care includes detox and residential treatment for drug and alcohol addiction, and co-occurring mental health issues including depression and eating disorders.

For 2022, cash basis revenue was $37M, with $13.4M EBITDA on mature operations, and $12.25M EBITDA including startup expenses for their third treatment center opened December 1, 2022. As of April 2023, the run rate on an as-if-accrual basis is ~$22-23M EBITDA, with all locations operating at ~90% occupancy.

The Company has separately incorporated entities for each treatment center, each real estate holding company, as well as entities for corporate shared marketing and management activities. The business operates as an out of network provider currently with most payors, but future plans include opening larger treatment centers under separate entities to accommodate the significant number of patients seeking in-network care, who are currently referred out.

DME, Bracing, Stimulator and Electrotherapy Provider

Starting in 1991 as a medical billing company, the need surfaced for capable back-office expertise that could focus on the billing and collections for both private practices and hospital-based doctor practices.

Noting an absence of high quality equipment providers with strong billing and collections capacity, many of the Company’s clients began to request durable medical equipment for their patients. Because of the trust that formed, the Company engaged with insurance networks, and became participating providers. Several of these networks are now closed to new DME providers and have been for many years.

This DME company was built from the ground up, now having an office in New Jersey that handles both NJ and NY; as well as two offices in the South Atlantic states. The North Carolina offices provide DME services to NC, VA and SC. while the NJ office does all the billing and collections. The focus is on Orthopedics, Pain, Podiatry and Spine. A professional team of clinical specialists has been assembled and are face to face with doctors every day in the operating room, surgical center or office.

The Company has grown as a leader in electrotherapy (TENS, EMS) and bracing (spine, knee, shoulder, etc.). With expansion onto military bases and a new initiative working with Anesthesiologists and their pain management programs continues to fuel additional incremental growth.

In 2021, the Company generated revenues of $4.4MM with an adjusted net income of $700k. The company anticipated 2022 revenue to exceed $4.6MM.

Medical Supply – Cardiology Supply Specialists

Available for acquisition is a medical supply business with a 25-year history of success, selling to both a national and international customer base. Offering a wide selection of custom packaged cardiology set up kits to both end users and distributors, the business has developed a very strong list of loyal clients.

A new operator is well positioned for extraordinary growth since future plans include facilities expansion, personnel additions, innovative product development, investment in further employee training, and increased catalog inventory items. With a base of customers exceeding 4000 and global interest coming from many thousands of medical facilities, the business will experience sustained growth for many years to come.